Investors turned wary on pharmaceutical stocks on Monday after a $253 million award against Merck & Co. over its withdrawn painkiller Vioxx.
*For more on this story,
read the full Reuters article.
Investors turned wary on pharmaceutical stocks on Monday after a $253 million award against Merck & Co. over its withdrawn painkiller Vioxx.
*For more on this story,
read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!